Sector Gamma AS
- SEC CIK
- 0001475373
- Latest filing
- Aug 12, 2026
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 9, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 31
- −6 vs. Q2 2022
- Portfolio value
- $388.0M
- −$58.9M (−13.2%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| GILDGilead Sciences, Inc. | Stock | 883,106 | $54.5M | 14.0% | +39,679+4.7% | Added | History |
| BIIBBiogen Inc. | COM | 110,230 | $29.4M | 7.6% | +17,733+19.2% | Added | History |
| INCYIncyte Corp | COM | 418,794 | $27.9M | 7.2% | −40,635−8.8% | Reduced | History |
| BMYBristol Myers Squibb Co | Stock | 353,627 | $25.1M | 6.5% | +41,931+13.5% | Added | History |
| CAHCardinal Health Inc | Stock | 358,700 | $23.9M | 6.2% | −27,288−7.1% | Reduced | History |
| MRKMerck & Co., Inc. | Stock | 253,159 | $21.8M | 5.6% | −161,179−38.9% | Reduced | History |
| MDTMedtronic plc | Stock | 269,957 | $21.8M | 5.6% | −20,564−7.1% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 46,032 | $20.9M | 5.4% | +11,732+34.2% | Added | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 166,080 | $17.4M | 4.5% | +30,331+22.3% | Added | History |
| CNCCentene Corp | Stock | 201,555 | $15.7M | 4.0% | +19,756+10.9% | Added | History |
| BSXBoston Scientific Corp | Stock | 387,184 | $15.0M | 3.9% | −145,551−27.3% | Reduced | History |
| CICigna Group | Stock | 50,517 | $14.0M | 3.6% | −15,766−23.8% | Reduced | History |
| BRKRBruker Corp | COM | 237,958 | $12.6M | 3.3% | −13,084−5.2% | Reduced | History |
| SGENSeagen Inc. | COM | 84,730 | $11.6M | 3.0% | +33,935+66.8% | Added | History |
| NUVANuvasive Inc | COM | 248,649 | $10.9M | 2.8% | +1,147+0.5% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 109,604 | $9.29M | 2.4% | +4,345+4.1% | Added | History |
| BAXBaxter International Inc | Stock | 169,028 | $9.10M | 2.3% | +169,028 | New | History |
| QGENQiagen N.V. | SHS NEW | 204,074 | $8.42M | 2.2% | +2,345+1.2% | Added | History |
| IONSIonis Pharmaceuticals Inc | COM | 164,223 | $7.26M | 1.9% | −1,216−0.7% | Reduced | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 11,988 | $5.00M | 1.3% | +203+1.7% | Added | History |
| SAGESage Therapeutics, Inc. | COM | 115,696 | $4.53M | 1.2% | −2,780−2.3% | Reduced | History |
| PTCTPTC Therapeutics, Inc. | COM | 86,692 | $4.35M | 1.1% | +1,828+2.2% | Added | History |
| CVSCVS Health Corp | Stock | 43,443 | $4.14M | 1.1% | −124,668−74.2% | Reduced | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 68,612 | $3.19M | 0.8% | −12,231−15.1% | Reduced | History |
| UHSUniversal Health Services Inc | CL B | 27,077 | $2.39M | 0.6% | 00.0% | Unchanged | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 45,520 | $1.89M | 0.5% | −701−1.5% | Reduced | History |
| VIRVir Biotechnology, Inc. | COM | 89,808 | $1.73M | 0.4% | −20,415−18.5% | Reduced | History |
| RIGLRigel Pharmaceuticals Inc | COM NEW | 1,346,904 | $1.59M | 0.4% | −119,774−8.2% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 6,921 | $1.39M | 0.4% | −35,923−83.8% | Reduced | History |
| NVAXNovavax Inc | COM NEW | 56,735 | $1.03M | 0.3% | +1,411+2.6% | Added | History |
| EMBCEmbecta Corp. | Stock | 5,246 | $151.0K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q2 2022 (7)
Positions held at the end of Q2 2022 that are gone from this filing.
| Security | Class | Shares in Q2 2022 | Value in Q2 2022 | % of portfolio in Q2 2022 | History |
|---|---|---|---|---|---|
| OGNOrganon & Co. | Stock | 356,089 | $12.0M | 2.7% | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 33,474 | $9.43M | 2.1% | History |
| ABTAbbott Laboratories | Stock | 49,205 | $5.35M | 1.2% | History |
| PFEPfizer Inc | Stock | 100,000 | $5.24M | 1.2% | History |
| QTRXQuanterix Corp | COM | 88,670 | $1.44M | 0.3% | History |
| SLGCSomaLogic, Inc. | CLASS A COM | 301,224 | $1.36M | 0.3% | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 123,713 | $964.0K | 0.2% | History |